Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents — Possible implications for new therapeutic approaches to Lyme disease
- 25 June 2002
- journal article
- review article
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 291, 125-137
- https://doi.org/10.1016/s1438-4221(02)80024-8
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazoleAPMIS, 1999
- In vitro-Empfindlichkeit von 30Borrelia-Stämmen gegenüber acht AntibiotikaInfection, 1996
- In vitro Antimicrobial Susceptibility Testing of Borrelia burgdorferi: Influence of Test Conditions on Minimal Inhibitory Concentration (MIC) ValuesZentralblatt für Bakteriologie, 1995
- Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferiAntimicrobial Agents and Chemotherapy, 1993
- Efficacy of clarithromycin for treatment of experimental Lyme disease in vivoAntimicrobial Agents and Chemotherapy, 1993
- In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxoneAntimicrobial Agents and Chemotherapy, 1992
- Ceftriaxone as Effective Therapy in Refractory Lyme DiseaseThe Journal of Infectious Diseases, 1987
- Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patientsJournal of Antimicrobial Chemotherapy, 1987
- Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migransJournal of the American Academy of Dermatology, 1985
- Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo CorrelationsThe Journal of Infectious Diseases, 1985